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Background: Under a conventional two-arm randomised trial design, participants are allocated to an intervention
and participating health professionals are expected to deliver both interventions. However, health professionals
often have differing levels of expertise in a skill-based interventions such as surgery or psychotherapy. An
expertise-based approach to trial design, where health professionals only deliver an intervention in which they
have expertise, has been proposed as an alternative. The aim of this project was to systematically review the use
of an expertise-based trial design in the medical literature.
Methods: We carried out a comprehensive search of nine databases—AMED, BIOSIS, CENTRAL, CINAHL, Cochrane
Methodology Register, EMBASE, MEDLINE, Science Citation Index, and PsycINFO—from 1966 to 2012 and performed
citation searches using the ISI Citation Indexes and Scopus. Studies that used an expertise-based trial design were
included. Two review authors independently screened the titles and abstracts and assessed full-text reports. Data
were extracted and summarised on the study characteristics, general and expertise-specific study methodology,
and conduct.
Results: In total, 7476 titles and abstracts were identified, leading to 43 included studies (54 articles). The vast
majority (88 %) used a pure expertise-based design; three (7 %) adopted a hybrid design, and two (5 %) used a
design that was unclear. Most studies compared substantially different interventions (79 %). In many cases, key
information relating to the expertise-based design was absent; only 12 (28 %) reported criteria for delivering
both interventions. Most studies recruited the target sample size or very close to it (median of 101, interquartile
range of 94 to 118), although the target was reported for only 40 % of studies. The proportion of participants
who received the allocated intervention was high (92 %, interquartile range of 82 to 99 %).
Conclusions: While use of an expertise-based trial design is growing, it remains uncommon. Reporting of study
methodology and, particularly, expertise-related methodology was poor. Empirical evidence provided some support for
purported benefits such as high levels of recruitment and compliance with allocation. An expertise-based trial design
should be considered but its value seems context-specific, particularly when interventions differ substantially or
interventions are typically delivered by different health professionals.
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Under a conventional two-arm randomised controlled
trial (RCT) (within-health professional) design, partici-
pants are randomly allocated to one of the two interven-
tions and all participating health professionals are
expected to deliver both interventions. However, if the
interventions are skill-based, and particularly when those
under evaluation differ substantially, health professionals
may (for example, surgeons or therapists) may have dif-
fering levels of expertise in the interventions, conduct
only one routinely, or have a preference for one over
another. These potential obstacles to the conduct of an
RCT have been noted particularly in surgery; many
surgeons may accept the need in principle for an RCT
but may struggle to reconcile their personal involvement
with their surgical experience and routine practice [1].
As a result, some may be reluctant to participate in a
standard, individually randomised RCT. An expertise-
based approach to trial design, in which participating
surgeons provide only the intervention in which they
have expertise, has been proposed to overcome this
problem [2]. As with the within-health professional
design, a patient is randomly allocated to an interven-
tion, the difference being that there are two sets of par-
ticipating health professionals, one for each intervention,
who will perform the allocated intervention. Purported
benefits of this design include increased surgical partici-
pation, recruitment, and compliance with randomisation,
addressing the learning curve effect as well as the desir-
ability from the perspective of the patient [2]. Although
such a design is not new [3], the profile of the design
has been raised and its use appears to becoming more
common. For some comparisons such as surgery versus
medical management, it has become the default design.
However, expertise-based designs have been criticized
on a number of grounds [4], including a number of
methodological considerations (for example, impact on
sample size). In particular, how ‘expertise’ should be de-
fined is uncertain but clearly is of critical importance.
The optimal approach to implementation is also unclear
[1, 5]. It may be that the expertise-based design is most
suited to certain research questions [6–12].
Although an expertise-based design has recently re-
ceived the most attention for surgical evaluation [1, 2], it
has been used in other areas (for example, psychother-
apy) [12]. The same issues exist for the delivery of other
interventions which are substantially skill-based and in
which individual practitioners may be familiar with only
a particular approach or have a strong preference for
one intervention over another. However, there is uncer-
tainty regarding under which circumstances an expertise-
based trial design is appropriate, how such studies are im-
plemented in practice, and whether the purported benefits
have been realised (for example, achieving recruitmentand high compliance with intervention). No comprehen-
sive review of expertise-based trials has been previously
carried out. A limited search was conducted previously
(160 citations) [2] but was restricted to surgery and ex-
tended only up to October 2003. Within the small number
of studies identified in that search, variation in reporting
and practice highlighted the need for both a comprehen-
sive search strategy and an evaluation of differences in
how such studies were carried out. For example, different
terms have been used to represent the same design (for
example, randomised-surgeon design). Beyond the surgical
area, other terms (for example, hierarchical and nested)
have been used to describe the same design [12]. Within
those that might be characterised as an expertise-based
design, there are variations in how ‘expertise’ was defined
(for example, surgeon self-certification versus objective
requirements) and how health professionals were assigned
to a treatment group (health professional preference or
randomisation). The aim of this review was to systematic-
ally review the use of an expertise-based trial design in the
medical literature in order to improve understanding of
the applicability, implementation, and implications of
using such a design so as to aid the design of future trials.
To achieve this, the objectives of the review were (i) to
identify the contexts in which an expertise-based trial
design has been used, (ii) to assess the methodological
variation in expertise-based trial design implementation
both in general and those aspects specifically related to
the expertise-based design, and (iii) to summarise the
reported experience of using such a design.Methods
The study protocol is available from the authors. Ethical
approval was not required for this research given its
focus and given that only publically available information
was used.Inclusion criteria
RCTs of two medical interventions that used an
expertise-based trial (either full or hybrid) design were
included (that is, those that used a randomised alloca-
tion of participants to skill-based interventions that were
delivered by non-overlapping groups of interventional-
ists). The following types of studies were not eligible for
inclusion: those that had been published only as proto-
cols or abstracts, trials with three or more intervention
arms, and trials in which the full-text reports were pub-
lished only in a non-English language journal. Systematic
(or narrative) reviews of expertise-based trials were not
eligible, but the included studies were assessed for inclu-
sion. No restrictions on the age or type of participants in
the trials were made.
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It was anticipated, from reviewing the results of a scop-
ing search, that it would be difficult to identify all rele-
vant studies from searching bibliographic databases
alone given the poor reporting of methods in the titles
and abstracts and the paucity of specific controlled
vocabulary terms in the major bibliographic databases.
To address this, a range of methods were used to re-
trieve reports of relevant trials. The databases searched
included Medical Literature Analysis and Retrieval
System Online (MEDLINE), Excerpta Medica dataBASE
(EMBASE), Cumulative Index to Nursing and Allied
Health Literature (CINAHL), BioSciences Information
Service of Biological Abstracts (BIOSIS), Cochrane
Central Register of Controlled Trials (CENTRAL),
Cochrane Methodology Register, Science Citation Index,
The Allied and Complementary Medicine Database
(AMED), and PsycINFO. In addition, cited reference
searches (using Institute for Scientific Information Cit-
ation Indexes and Scopus), references of included arti-
cles, and key author searches were undertaken. If a
study had been referred to as an expertise-based trial in
another report but the design was unclear in the related
published literature, an investigator was contacted to
confirm. Searches were undertaken from 1966 onwards
or, from the start of database coverage if after 1966. The
MEDLINE and EMBASE multi-file search strategy,
which was used to search these databases concurrently,
was developed first and translated for other databases.
The search strategies are provided in Additional file 1.
Selection of studies
Two review authors (JC and CB, AE, GSM, or TB) inde-
pendently screened the titles and abstracts of all reports
identified by the search strategy. The full versions of ar-
ticles not definitely excluded at that stage were obtained
for full-text assessment, which will be carried out by two
reviewers as before. Where they occurred, differences of
opinion were discussed; if necessary, a blinded third re-
view author acted as arbitrator. If appropriate, a clinical
area expert was consulted. Methods articles were not in-
cluded but were set aside for future reference and, if
appropriate to do so, were considered in the discussion.
Data collection and analysis
Data on the trial characteristics and context (year of
publication, funding [13], clinical area, interventions
under evaluation, and type of comparison), expertise-
based design methodology and related reporting (type of
design, reporting including stated advantages and disad-
vantages, interventionalist mechanism of allocation, eli-
gibility criteria, and number), general study methodology
and conduct (randomisation, blinding, and study size
and compliance regarding allocation), and details on theprimary outcome and statistical analyses were extracted.
One reviewer (JC) carried out data extraction of in-
cluded articles (using a pro forma specifically designed
for the purpose). A second reviewer (AE or GM) inde-
pendently assessed a random sample of 25 % of included
studies. Data were summarised. Owing to the relatively
small number of included studies, a planned statistical
analysis to compare factors across trial types was not
carried out.
Results
In total, 7476 titles and abstracts were identified from
the search of 9 databases (Fig. 1); after removal of dupli-
cates, 3247 were screened for inclusion. Of these, 3092
were excluded and 155 articles were selected for full-text
assessment. A further 19 articles were identified from
the references of included studies, leading to a total of
157 studies (174 articles) that were full-text-assessed. Of
these, 117 studies (125 articles) were excluded, leaving
40 studies (49 articles) that, combined with three studies
(five articles) identified from a published review, led to
43 studies (54 articles) in total. The list of included stud-
ies is provided in Additional file 2. Table 1 shows the
study characteristics and context of the included studies.
The earliest publication was in 1982; most (69 %) were
published from 2000 onwards. The vast majority re-
ceived funding from public bodies in whole or part,
whereas partial or full funding was received less com-
monly from a charity or a commercial source. The clin-
ical areas represented varied, and mental health (26 %)
and musculoskeletal (19 %) were the most common. The
most common intervention types were a procedure and
psychotherapy (40 and 37 % for interventions 1 and 2
for both). The comparisons overwhelmingly focussed on
substantial differences between interventions (79 %).
Table 2 reported the methodology and reporting relat-
ing to the expertise-based trial design. The vast majority
(88 %) used a pure expertise-based design in which
health professionals deliver only one of the two interven-
tions; only three (7 %) used a hybrid designin which
some health professionals could deliver both. For two
studies the design that was unclear (5 %). Ten used ter-
minology to refer to the design, and six different names
were used. The level of detail reported in the abstract
varied from stating the design name in six (14 %) studies
to giving no details in 15 (35 %). A variety of advantages
of using an expert-based design were stated: the most
common were ensuring a balance of health professionals
in terms of interest and commitment (9 %), addressing
learning (7 %), ensuring that the intervention is delivered
by someone with expertise in order to avoid criticism
(5 %), and reducing cross-over (5 %). Fewer disadvantages
were stated; the more common were that intervention de-
liverers were not representative of clinical practice or may
3092 titles and abstracts 
excluded at abstract
screening stage
Fulltext assessment:
155 articles selected from screening
19 further articles identified from references
174 articles (157 studies) assessed in TOTAL
117 studies (125 articles) excluded
50 interventions delivered by the same individual
6 three or more arms
19 expertise not required to deliver both interventions
14 additive study
8 cluster RCT
7 not at primary report
6 quasi-randomised
4 non-randomised study
4 placebo
3 health professional trial
1 animal trial
1 duplicate
1 commentary
1 pilot
43 studies (54 articles) included
3 studies (5 articles) 
identified from 
review not 
identified by the 
search strategy
7476 titles and abstracts identified from primary search:
AMED 172
BIOSIS 614
Central 949
CINAHL 770
CMR 293
MEDLINE/Medline In-Process/EMBASE              1903
PsycINFO 782
SCI 1513
Web of Science citation search 421
Scopus citation search 59
3247 titles and abstracts screened after duplicates 
Fig. 1 PRISMA Flow diagram. AMED, The Allied and Complementary Medicine Database; BIOSIS, BioSciences Information Service of Biological
Abstracts; CENTRAL, Cochrane Central Register of Controlled Trials; CINAHL, Cumulative Index to Nursing and Allied Health Literature; CMR,
Cochrane Methodology Register; EMBASE, Excerpta Medica dataBASE; MEDLINE, Medical Literature Analysis and Retrieval System Online; RCT,
randomised controlled trial; SCI, Science Citation Index
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that the delivery of interventions may vary between groups
beyond the allocated intervention (5 %). Under half re-
ported the method of allocation of health professoinal to
intervention group; eight (19 %) interestingly used ran-
domisation, five (12 %) followed usual practice, four
followed interventionalist preference (9 %), and in one
case (2 %) the type of health professional was defined as
part of the research question. Criteria for delivering an
intervention varied between groups and involved one or
more of health professional training/grades, years of ex-
perience in and/or number of cases of delivering the inter-
vention, prior training and/or supervision in using theintervention, specified outcome performance level, recom-
mendation by colleague, experience of working with pa-
tient group, and willingness to learn a new procedure.
Only 12 (28 %) stated the criteria for delivering both inter-
ventions. A substantial number (21,49 %) did not give the
number of health professionals delivering the interven-
tions for both groups. The number of health profes-
sionals was similar for the two arms (medians of 6 and
5, respectively).
Details regarding general study methodology and con-
duct are shown in Table 3. Reporting of participant ran-
domisation methodology was adequate for the majority
of studies (58 and 60 % for sequence generation and
Table 1 General study characteristics and context (n = 43 unless
otherwise stated)
Number Percentage
Year of publication
1980–1989 2 5
1990–1999 11 26
2000–2009 23 53
2010–2012 7 16
Funding (n = 28)
Charity 3 11
Commercial 1 4
Public body 14 50
Mixed 10 37
Clinical area
Cardiology 5 5
Emergency care 1 2
Gastroenterology 2 5
General medicine 4 9
Geriatrics 1 5
Mental health 11 26
Musculoskeletal 8 19
Neurology 3 7
Obstetrics and gynaecology 2 5
Oncology 1 2
Ophthalmology 1 2
Substance abuse 4 5
Intervention 1
Acupuncture 1 2
Chiropractic 2 5
Clinical management
(various)
1 2
Physiotherapy 3 7
Procedure 17 40
Psychotherapy 17 40
Rehabilitation management
(various)
2 5
Intervention 2
Anaesthetic 1 2
Chiropractic 1 2
Clinical management
(various)
3 7
Clinical management
(various)/procedure
1 2
Physiotherapy 3 7
Procedure 16 37
Psychotherapy 16 37
Rehabilitation management
(varied)
2 5
Table 1 General study characteristics and context (n = 43 unless
otherwise stated) (Continued)
Difference between interventions
Minor 8 19
Substantial 34 79
Different type of care 1 2
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outcome assessment was known to be performed in 12
(28 %) studies, but blinding of participants was known
to be performed in only one (2 %). Most studies were
single-centre RCTs (median of 1, interquartile range
(IQR) of 1 to 5). Study size was typically moderate (111,
IQR of 62 to 226). Most studies recruited the target
number or very close to it (101, IQR of 94 to 118), al-
though the target size was reported for only 40 % of
studies. The proportion of participants who received the
allocated intervention was high (92 %, IQR of 82 to
99 %). For those that reported this aspect, occurrences
of cross-over between interventions or receiving a ‘third’
(non-trial) intervention were rare. Table 4 reports details
on the primary outcome. The most common outcomes
were type of disease and specific quality of life (29 %)
followed by other patient-reported outcomes and
process measure (17 % for both). The number of obser-
vations available to analyse was poorly reported (26
studies, or 60 %). Details regarding the statistical analysis
carried out are provided in Table 5. Almost all studies
(98 %) carried out an analysis by randomised groups.
Eight (19 %) studies had a compliance analysis, and only
two (5 %) adjusted for clustering of outcome by
interventionalists.
Discussion
This systematic review identified from across the med-
ical literature a number of RCTs that used an expertise-
based trial design. An expertise-based design differs
from the conventional (within-health professional)
design by allowing different groups of health profes-
sionals to deliverer the interventions under evaluation as
opposed to requiring participating health professionals
to deliver both of (or all, where there are three or more)
the interventions. It has been suggested that the design
is able to address [2, 3] some of the challenges of con-
ducting an RCT of skill-based interventions which a
conventional design is not. Although the design has been
in use for over 30 years and use has been growing in
recent years, it remains uncommon.
Previous limited reviews [2, 14] had identified fewer
than 10 studies using an expertise-based design and fo-
cussed only on surgery. Uniquely, this review had a full
and comprehensive systematic search with information
on the context of the study, the methodology of the trial
Table 2 Expertise-based design methodology and related reporting (n = 43 unless otherwise stated)
Number Percentage
Expertise-based design type
Pure 38 88
Hybrid 3 7
Unclear 2 5
Name used (n = 24)
Expertise-based 2 8
Double randomisation 2 8
Randomised to surgeon 2 8
Non-randomised surgeon design 1 4
Randomised-surgeon 1 4
Surgeon-randomised 2 8
None 15 63
Reporting of expertise-based design in abstract
Design name 6 14
Deliverers of interventions stated to be different 9 21
Details regarding health professionals delivering one intervention 7 16
Details regarding health professional delivering both interventions 6 14
No details 15 35
Reported advantages (n = 20)
Ensuring intervention was delivered by someone with expertise to avoid criticism of the study 2 5
Balance of health professionals (e.g., interest, commitment, and prior knowledge of intervention) 4 9
Randomisation of health professional ‘consistent with efficacy trial’ 1 2
Following preference will reduce non-compliance 1 2
Using randomisation of health professional strengthens generalisability of findings 1 2
Eliminates learning of the intervention 3 7
Eliminates ethical concerns with intervention deliverer not doing what they would do outside of the trial 1 2
Delivery of intervention maximised (and may reduce adverse events) 1 2
Ensures experience in control group 1 2
Reduces cross-over between group compared with conventional study 2 5
Avoid non-compliance with allocation because of non-familiarity 1 2
Health professionals delivering their preferred intervention 1 2
Following usual practice reduces non-compliance with allocation 1 2
Reported disadvantages (n = 9)
Health professionals delivering interventions may not be representative of practice 1 2
Health professionals delivering interventions may not be balanced (e.g., motivation and prior experience) unless selected 4 9
Delivery may vary in other ways between groups because of different health professionals delivering the interventions 2 5
Disagreement between recruiter and health professional delivering the intervention regarding eligibility led to the
intervention not being performed in some cases
1 2
Addition of new intervention and deliverer may create expectation bias 1 2
Allocation of intervention deliverers
Randomised 8 19
Usual practice 5 12
Preference 4 9
Defined by research question 1 2
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Table 2 Expertise-based design methodology and related reporting (n = 43 unless otherwise stated) (Continued)
Not stated 25 58
Criteria for delivering intervention 1
Number of prior cases 2 4
Number of years of experience and prior cases 1 2
Number of years of experience and training in intervention 1 2
‘Qualified’ intervention deliverer 1 2
Training of therapy and group supervision 1 2
Profession qualification 3 6
Prior training and experience of intervention 1 2
Trained in delivering intervention 4 8
Recommendation by colleagues as expert 1 2
Experience of working with patient group 1 2
Willingness to learn new intervention 1 2
Without prior experience of intervention (training then provided) 1 2
None (training/supervision provided as part of the study) 3 7
Not stated 22 51
Criteria for delivering intervention 2
Number of years of experience and specific outcome levels to be achieved 1 2
Years of experience 1 2
Number of years of experience and prior cases 1 2
Recommendation by colleagues as expert 1 2
Experience of working with patient group 1 2
Professional qualification 2 4
Preference and no training in alternative intervention 1 2
Willingness to learn new intervention 1 2
Interest in patient group 1 2
None (trained as part of the study) 2 5
None stated 31 72
Criteria provided for both intervention 1 and 2 deliverers 12 28
Number of health professionals delivering intervention 1
Reported 30 69
Median (interquartile range), range 6 (2–12), 1–58
Number of health professionals delivering intervention 2
Fully reported 23 53
Median (interquartile range), range 5 (2–19), 1–63
Cook et al. Trials  (2015) 16:241 Page 7 of 10(both expertise-related and generic), and the reported
views of the trialists collected and summarised. It shows
that the design has been used beyond surgical interven-
tions where its use has been previously proposed [2, 3, 15]
and covers many clinical areas and evaluations of non-
pharmacological interventions. The potential value over a
conventional design appears to be case-specific and is
clear in two main circumstances. One is where two skill-
based interventions that are substantially different from
one another are to be compared (for example, cognitive
behavioural therapy and limited professional support); thisis the situation where they have most commonly been
used. Another setting where they have been used and
seem particularly appropriate (or perhaps natural to use)
is when the interventions are typically delivered by an-
other type of health professional (for example, a compari-
son of coronary artery bypass graft and stenting for the
treatment of coronary artery disease where they are deliv-
ered by a surgeon and a cardiologist respectively, as is the
case in some countries). Two surveys of preferences re-
garding trial design showed differing levels of support for
an expertise-based design, suggesting that it merits
Table 3 Study methodology and conduct (n = 43 unless
otherwise stated)
Number Percentage
Intervention deliverers–randomisation sequence generation
Adequate 1 10
Inadequate 0 0
Unclear 9 90
Intervention deliverers–randomisation allocation concealment
Adequate 1 10
Inadequate 0 0
Unclear 9 90
Participants–randomisation sequence generation
Adequate 25 58
Inadequate 0 0
Unclear 18 42
Participants–randomisation allocation concealment
Adequate 26 60
Inadequate 2 5
Unclear 15 35
Blinding–primary outcome assessment
Yes 12 28
No 27 63
Unclear 4 9
Blinding–participants
Yes 1 2
No 34 79
Unclear 8 19
Number of centres
Reported 42 98
Median (IQR) 1 (1–5)
Study size
Reported 42 98
Median (IQR) 111 (62–226)
Percentage of target size recruited
Reported target size 17 40
Median (IQR) 101 (94–118)
Percentage received full intervention
Reported 31 74
Median (IQR) 92 (82–99)
Cross-over to other study intervention
Reported 18 42
Median (IQR) 0 (0–2)
“Third” intervention
Reported 15 35
Median (IQR) 0 (0–0)
IQR interquartile range
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which it would be used [6, 9].
Reporting of the use of the expertise-based design
methodology in the abstract was highly variable, and in-
sufficient details regarding key methodological features
of expertise-based trials were provided. Around half
failed to provide details on the interventionalists deliver-
ing the interventions, a key piece of information for
interpreting and assessing the applicability of the find-
ings. Furthermore, we identified the use of a hybrid
approach in a small number of studies, although it is
possible that more studies adopted this design, but this
information was not provided in the trial reports [5, 16].
Expertise-based trials were typically single-centre studies
of moderate size with around 10 interventionalists
involved in the study with a patient-reported primary
outcome. Two of the main purported benefits appeared
to be supported by the empirical evidence. Achievement
of the target recruitment was very high, although the
target size was often not reported, leading to some un-
certainty regarding this finding. However, compliance
with the allocated intervention was generally very high
(median of at least 90 %), and occurrences of cross-over
between intervention groups or receiving a third non-
trial intervention were rare.Table 4 Primary outcome(s) (n = 43 unless otherwise stated)
Number Percentage
Primary outcome
Number of primary outcomes
None 17 40
1 15 35
2 5 12
3 3 7
4 2 5
5 0 0
6 1 2
Type of outcome (n = 48)
Pain 4 8
Generic quality of life 2 4
Disease-specific quality of life 14 29
Treatment success 4 8
Other patient-reported outcome 8 17
Mortality, composite including mortality 2 4
Process measure 8 17
Functional measure 6 13
Valid observations (n = 26)a, median
(interquartile range), range
127 (78–435), 24–4752
aFor studies with more than one primary outcome, the maximum available
number of observations was used
Table 5 Statistical analysis methodology (n = 43 unless
otherwise stated)
Number Percentage
Analysis groups according to randomised groups
Yes 42 98
No 1 2
Unclear 0 0
Analysis adjusting for non-compliance carried out
Yes 8 19
No 35 81
Unclear 0 0
Compliance analysis type
As treated groups 3 7
Intervention completer subset analysis
(full compliance)
2 5
Intervention completer subset analysis
(partial and full compliance)
2 5
Randomisation-based analysis
(method unclear)
1 2
N/A 35 81
Analysis adjusting for clusteringa
Yes 2b 5
No 41 95
Unclear 0 0
N/A not available
aAnalyses carried out were mixed-effect models: one with two levels (intervention
deliverer and) and one with three (site, intervention deliverer, and participant). bIn
one study, the sample size was adjusted to account for clustering by using
an intracluster correlation coefficient (ICC) of 0.02; for the other study the
observed ICC of the higher level(s) was reported for the two primary outcomes
(retention and engagement) under a two level (therapist and participant) and a
3 level model (site, therapist and participant) as 0.180 and 0.22 and 0.099 and
0.110 respectively
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randomisation was suboptimal, as has been repeatedly
shown for RCTs of both pharmacological and non-
pharmacological interventions [17]. Blinding of the
primary outcome assessment and of participation was
not typically performed, perhaps reflecting the nature
of the trial comparison and the types of interventions
under evaluation. Studies appeared to adopt a more
pragmatic approach to study design [2]. Only two
studies adjusted the analysis for clustering of outcome
by interventionalist, even though failure to do this
could lead to an overly precise estimate, and no stud-
ies provided justification for why this was not done
[7, 18].
A number of potential advantages have been pro-
posed to support the use of an expertise-based trial
design, including addressing the learning curve and
possible differences in expertise among health profes-
sionals between interventions (sometimes referred to as
differential expertise bias, which is particularly likely ifa new intervention is compared with an older one),
ethical concerns of intervention deliverers about per-
forming a procedure they are not experienced or
comfortable with, reassurance for patients that their
intervention will be delivered by someone with appro-
priate ‘expertise’, improved compliance, avoidance of
systematic bias introduced unconsciously if a prefer-
ence for one intervention exists, and increased partici-
pation of interventionalists [2, 3]. However, a number
of potential drawbacks have also been noted: the feasi-
bility of two different interventionalists being available,
imbalances between interventionalist groups in terms
of ability and experience, the need for third-party re-
cruitment, and reduced applicability of the study results
[2, 4, 6, 15, 19]. This review generally reinforced the
proposed advantages and disadvantages but highlighted
that some of the advantages are conditional on the im-
plementation of the expertise-based design regarding
definition of “expertise” (for example, elimination learn-
ing). Additional disadvantages were identified, such as
the possibility of an expectation bias being created if a
new intervention is delivered by a different individual
[20], having different individuals recruiting and deliver-
ing the intervention which can lead to disagreement
regarding suitability for receiving the intervention [21],
and the possibility that the intervention may differ in
ways beyond the treatment allocation [20, 22].
There were a number of limitations to this review.
Owing to the inconsistency of reporting highlighted in
included studies, it seems likely that some eligible
expertise-based trials were not identified, as reference to
this aspect of the design was not made in the title or ab-
stracts or possibly anywhere in the text. Inclusion was
restricted to two-arm individually randomised parallel
group trials, although a form of expertise-based design
could be used in other settings (for example, three-arm
or cluster RCT). Additionally, the search was conducted
only up to 2012. Owing to the small numbers of in-
cluded studies, it was not possible to formally compare
subtypes of trials as planned. Finally, no formal compari-
son has been made with conventional (within-health
professional) trials.
This review expands the current understanding of
expertise-based trials. Further work exploring the view
and experience of health professionals and those in-
volved in trial design should be carried out to further in-
crease understanding of the decision-making process
regarding design choice. We recommend improved and
more consistent reporting, and reports should state ex-
plicitly who delivered the interventions; the term ‘ex-
pertise-based’ could be used in the title or abstract of
trial reports with explicit details regarding the number
of interventionalists in each arm with any criteria for
eligibility reported in the trial report.
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Although the use of an expertise-based trial design is
growing, it remains uncommon. An expertise-based trial
design is an option that should be considered by trials,
particularly in light of the high level of recruitment to tar-
get and compliance with allocation observed [23]. Its value
appears to be context-specific, particularly where interven-
tions differ substantially or interventions are typically de-
livered by different health professionals. Reporting of
expertise-based trials is suboptimal in providing details re-
lating to the expertise design and requires improvement.
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